Description

Buy Lortab 7.5/325mg Online

You should not use Lortab 7.5/325mg (Hydrocodone Bitartrate and Acetaminophen) if you are allergic to acetaminophen (Tylenol) or hydrocodone, or if you have recently used alcohol, sedatives, tranquilizers, or other narcotic medications.
Do not use Lortab 7.5/325mg (Hydrocodone Bitartrate and Acetaminophen) if you have taken a MAO inhibitor in the past 14 days. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, phenelzine, rasagiline, selegiline, and tranylcypromine.
Some medicines can interact with hydrocodone and cause a serious condition called serotonin syndrome. Be sure your doctor knows if you also take medicine for depression, mental illness, Parkinson’s disease, migraine headaches, serious infections, or prevention of nausea and vomiting. Ask your doctor before making any changes in how or when you take your medications.

Lortab 7.5/325mg this Product belong to the Opioid Narcotic Pain Medication Group, Classified by the F.D.A. On Schedule of Controlled Substances, for Exclusive use of Clinics & Hospitals; This is why is hard for other Sources to get this from the Original Laboratory approved by the F.D.A. Like the ones We Offer, and also in a Lower Price, because of all the Expenses they represent

And also, this is why all other Non Reliable and Suspicious Sources that Offer this Product, they are: Street Unknown Drug, Fake Product, Weak Generic, Home Made or Counterfeit, from other unknown Countries with no Health Regulations, like Pakistan, India, China, Asian, or Central and South America, and also, we are the top # 1 most Reliable and Best Rated Source, from over 300 places, there were They Recommended You with Us.
Buying products from the street, you have the risk to get poisoned or strong infection by not regulated fake drug mix they offer, made in Clandestine laboratory in the worst health conditions

FORMULATION:

Acetaminophen 325mg.
Hydrocodone Bitartrate 7.5mg.

BOXED WARNING
DOSAGE & INDICATIONS

Hydrocodone bitartrate and acetaminophen tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

Limitations of Use

Because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses reserve hydrocodone bitartrate and acetaminophen tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics):

have not provided adequate analgesia, or are not expected to provide adequate analgesia

Lortab 7.5-325mg contraindications
Hydrocodone bitartrate and acetaminophen tablets are contraindicated in patients with:

Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment WARNINGS

Known or suspected gastrointestinal obstruction, including paralytic ileus WARNINGS

Hypersensitivity to hydrocodone or acetaminophen (e.g., anaphylaxis) WARNINGS, ADVERSE REACTIONS

WARNINGS
Hydrocodone bitartrate and acetaminophen tablets contain hydrocodone, a Schedule II controlled substance. As an opioid, hydrocodone bitartrate and acetaminophen tablets expose users to the risks of addiction

DEPENDENCE

Although the risk of addiction in any individual is unknown, it can occur in patients appropriately prescribed hydrocodone bitartrate and acetaminophen tablets. Addiction can occur at recommended dosages and if the drug is misused or abused.

Assess each patient’s risk for opioid addiction, abuse, or misuse prior to prescribing hydrocodone bitartrate and acetaminophen tablets, and monitor all patients receiving hydrocodone bitartrate and acetaminophen tablets for the development of these behaviors and conditions. Risks are increased in patients with a personal or family history of substance abuse (including drug or alcohol abuse or addiction) or mental illness (e.g., major depression). The potential for these risks should not, however, prevent the proper management of pain in any given patient. Patients at increased risk may be prescribed opioids such as hydrocodone bitartrate and acetaminophen tablets, but use in such patients necessitates intensive counseling about the risks and proper use of hydrocodone bitartrate and acetaminophen tablets along with intensive monitoring for signs of addiction, abuse, and misuse.